Clinical Trial

Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 15, 2025 (before its estimated June 6, 2025 completion). Its status may not reflect the trial's current state.
Summary
The SIMBA Capsule is a small, single-use, ingestible capsule that allows for the non-invasive sampling of small bowel contents using purely mechanical means. The study will compare the microbial and metabolomics analysis from the sample collected with the capsule series, to same-participant symptom questionnaires and stool microbial analysis.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-11-21; most recent amendment 2025-04-10.
Status change: Not Yet Recruiting → Recruiting 2023-01-04
Trial Details
NCT Number NCT05633706
Lead Sponsor Nimble Science Ltd.
Collaborators: Mitacs, University of Calgary
Conditions Irritable Bowel Syndrome, Crohn Disease, Celiac Disease, Ulcerative Colitis, Functional Dyspepsia, Type 2 Diabetes, Healthy
Enrollment 300 participants
Start Date 2023-01-09
Primary Completion 2025-06-06 (estimated)
Study Completion 2025-06-06 (estimated)
Updated on ClinicalTrials.gov 2025-04-15